ORTEXORTEX News
Live short interest, options flow, and signals — free on ORTEX.Sign up free →
Market Commentary

Insiders Dump and Buy Across Markets

By ORTEX News · Edited by , Editor, ORTEX NewsUpdated 1 min read

Produced automatically from ORTEX data and published under the ORTEX News editorial standards set by Peter Hillerberg, Editor, ORTEX News. How we publish

ShareXLinkedInReddit

The most striking cluster in recently filed disclosures comes from NVDA. Independent director Mark A. Stevens filed sales totalling more than $410 million across just three days in early September. The trades spanned multiple transactions on August 31, September 1, and September 2, with the largest single filing worth $98.5 million. The significance score on each transaction was modest, suggesting these were likely pre-arranged disposals rather than discretionary selling. Even so, the sheer scale stands out.

On the buying side, Ma Jianrong, Executive Chairman of Shenzhou International Group, filed purchases worth over $51 million across four days in early September. Shenzhou is a Hong Kong-listed garment manufacturer and Ma's repeated open-market buying across consecutive sessions signals personal conviction in the stock at current levels.

NMIH CEO Adam Pollitzer filed a $7.7 million sale in NMI Holdings on September 4. The trade carried a significance score of 3, suggesting it was discretionary rather than routine.

CAT CEO Joseph Creed filed a $9.8 million sale on September 1, though with a low significance score of 1, pointing to a pre-planned disposal.

The argenx CEO Timothy Van Hauwermeiren filed a $21 million sale in ARGX on September 5, also carrying a low significance score.

Note: ORTEX's first-party SEC EDGAR Form 4 tables were unavailable in this environment, so US trades above rely on the vendor insider dataset. Activist 13D filings could not be retrieved.

Stocks in this article

How this article was generated

Generated
7 Nov 2026, 20:12
Prompt version
v1.0
Data sources
Institutional positioningAlt DataIndex Rebalance

ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.